J
John A. Howington
Researcher at NorthShore University HealthSystem
Publications - 50
Citations - 3512
John A. Howington is an academic researcher from NorthShore University HealthSystem. The author has contributed to research in topics: Lung cancer & Cancer. The author has an hindex of 21, co-authored 49 publications receiving 3031 citations. Previous affiliations of John A. Howington include University of Cincinnati & Northwestern University.
Papers
More filters
Journal ArticleDOI
Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
TL;DR: Surgical resection remains the primary and preferred approach to the treatment of stage I and II NSCLC, and mediastinal lymph node sampling at the time of curative intent surgical resection can be performed without increased morbidity.
Journal ArticleDOI
Treatment of Non-small Cell Lung Cancer Stage I and Stage II: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Walter J. Scott,John A. Howington,Steven J. Feigenberg,Benjamin Movsas,Katherine M.W. Pisters +4 more
TL;DR: In this paper, a review of early stage non-small cell lung cancer (NSCLC) was conducted based on clinical relevance and the amount and quality of data available for analysis.
Journal ArticleDOI
American College of Chest Physicians and Society of Thoracic Surgeons Consensus Statement for Evaluation and Management for High-Risk Patients With Stage I Non-small Cell Lung Cancer
Jessica S. Donington,Mark K. Ferguson,Peter J. Mazzone,John R. Handy,Matthew J. Schuchert,Hiran C. Fernando,Billy W. Loo,Michael Lanuti,Alberto de Hoyos,Frank C. Detterbeck,Arjun Pennathur,John A. Howington,Rodney J. Landreneau,Gerard A. Silvestri +13 more
TL;DR: Therapeutic options for the treatment of high-risk patients are evolving quickly, and improved radiographic staging and the diagnosis of smaller and more indolent tumors push the risk-benefit decision toward parenchymal-sparing or nonoperative therapies in high- risk patients.
Journal ArticleDOI
Video-Assisted Thoracoscopic Lobectomy Is Less Costly and Morbid Than Open Lobectomy: A Retrospective Multiinstitutional Database Analysis
Scott J. Swanson,Bryan F. Meyers,Candace Gunnarsson,Matthew Moore,John A. Howington,Michael A. Maddaus,Robert McKenna,Daniel L. Miller +7 more
TL;DR: Lobectomy performed by the VATS approach as compared with an open technique results in shorter length of stay, fewer adverse events, and less cost to the hospital.
Journal ArticleDOI
Comparing robot-assisted thoracic surgical lobectomy with conventional video-assisted thoracic surgical lobectomy and wedge resection: results from a multihospital database (Premier).
Scott J. Swanson,Daniel L. Miller,Robert McKenna,John A. Howington,M. Blair Marshall,Andrew Yoo,Matthew Moore,Candace Gunnarsson,Bryan F. Meyers +8 more
TL;DR: Hospital costs and clinical outcomes for VATS lobectomies and wedge resections versus RATS seem to have higher hospital costs and longer operating times, without any differences in adverse events.